Swiss National Bank - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 80 filers reported holding CTI BIOPHARMA CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2016$185,000
-40.7%
360,150
+42.1%
0.00%
-100.0%
Q4 2015$312,000
-15.7%
253,5000.0%0.00%0.0%
Q3 2015$370,000
-16.1%
253,500
+12.2%
0.00%0.0%
Q2 2015$441,000
+16.7%
225,900
+8.1%
0.00%0.0%
Q1 2015$378,000
-16.0%
209,000
+9.7%
0.00%
-50.0%
Q4 2014$450,000
-2.4%
190,6000.0%0.00%0.0%
Q3 2014$461,000
+16.7%
190,600
+35.8%
0.00%
+100.0%
Q2 2014$395,000140,4000.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q1 2016
NameSharesValueWeighting ↓
PYRRHO CAPITAL MANAGEMENT, LP 608,194$1,186,0000.58%
Lombard Odier Asset Management (USA) Corp 2,768,341$5,398,0000.38%
Rotella Capital Management, Inc. 43,666$85,0000.07%
TWO SIGMA SECURITIES, LLC 19,994$39,0000.06%
OXFORD ASSET MANAGEMENT LLP 1,214,227$2,368,0000.06%
Candriam S.C.A. 1,445,000$2,818,0000.06%
WASHINGTON TRUST Co 410,616$801,0000.05%
DRW Securities, LLC 250,000$488,0000.05%
GLOBEFLEX CAPITAL L P 120,000$234,0000.04%
First Heartland Consultants, Inc. 74,624$146,0000.04%
View complete list of CTI BIOPHARMA CORP shareholders